FDA Adverse Event Malfunction Summary report: N

INCEPTA

MDR report key: 3040699 · Received April 8, 2013

Report

Report Number
2124215-2013-00659
Event Type
Malfunction
Date Received
April 8, 2013
Date of Event
January 8, 2013
Report Date
January 8, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A ROUTINE DEVICE INTERROGATION, A COMMANDED SHOCK IMPEDANCE MEASUREMENT GREATER THAN 125 OHMS WAS OBSERVED IN THE TRIAD CONFIGURATION. FOLLOWING A PROGRAMMER UPGRADE, SHOCK IMPEDANCE MEASUREMENTS IN THE TRIAD CONFIGURATION WERE WITHIN ACCEPTABLE LIMITS. NO FURTHER TESTING WAS PERFORMED AND THE DEVICE CURRENTLY REMAINED IN THE TRIAD CONFIGURATION. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED DURING THIS CLINICAL OBSERVATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
142812 INCEPTA IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E161

Patients

Seq Age Sex Outcome Treatment
1 63 YR 0185| E161| T175